IRF1 can inhibit RCC proliferation, and STAT1/IRF1 activates caspase-7-mediated apoptosis in RCC cells; meanwhile, the JAK2/ STAT1/IRF1 pathway also induces PD-L1 expression in ccRCC cells. Here, JAK2 is linked to renal cell carcinoma.